Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Leaving Seoul inspired and grateful.
It was a true honor to serve on the GBCC 2026 Steering Committee and Consensus Panel, and to spend these days exchanging knowledge, ideas, and perspectives with colleagues from around the world.
I was sincerely impressed by the scale, quality, and impact of this international conference, as well as by the energy and competence of the breast cancer community gathered in Seoul.
Deeply grateful to my Korean colleagues for the warm welcome and wonderful hospitality!”
Other articles about Breast Cancer on OncoDaily
